Cycurion Receives Nasdaq Delisting Notice; Plans Appeal
Cycurion, Inc. announced it received a delisting determination letter from Nasdaq because its common stock bid price fell below the $1.00 minimum for 31 consecutive business days. Due to a reverse stock split within the past year, the company is not eligible for the standard compliance period, and trading is expected to be suspended on July 21, 2026, if a hearing is not requested. Cycurion plans to timely request a hearing before the Nasdaq Hearings Panel by July 17, 2026, which will stay the suspension and allow its stock to continue trading during the appeal process. The company emphasized that this does not impact its operations, which continue to show strong business momentum with an annual revenue run rate exceeding $28 million.
Key Highlights
- Received Nasdaq delisting determination letter for not meeting minimum bid price requirement.
- Common stock bid price was below $1.00 for 31 consecutive business days (May 26 - July 9, 2026).
- Ineligible for customary 180-day compliance period due to 1-for-30 reverse stock split on Oct 27, 2025.
- Trading expected to be suspended on July 21, 2026, without a timely hearing request.
- Company plans to timely request a hearing before the Nasdaq Hearings Panel by July 17, 2026.
- A timely hearing request will stay the suspension of the Company's securities.
- Common stock will remain listed and trading on Nasdaq during the appeal process.
- Company maintains an annual revenue run rate exceeding $28 million.
Price Impact
More from CYCU